Funded Startups in Carlsbad
Carlsbad, California has produced a consistent stream of venture-backed companies across the 40 most recent funding events in the dataset, spanning late 20…
Carlsbad, California has produced a consistent stream of venture-backed companies across the 40 most recent funding events in the dataset, spanning late 2020 through November 2025. Life sciences dominates — biotechnology and health care companies account for roughly half the entries, with notable rounds including Allez Health's $60M Series A (May 2024), Nalu Medical's $50M venture round (September 2025), and Carlsmed's $53M raise (March 2024). Outside life sciences, hardware and manufacturing are represented: Aptera closed a $75M venture round in October 2025 — the largest disclosed round in the set — while Airspace pulled in a $70M Series D in May 2022.
Activity in 2025 shows broadening into AI and data, with GigaIO closing a $21M Series B in July, Sleep.ai raising $6M in August, and LenderSquared completing a $340K seed in October. Biotech deal flow remained active through the same period, with Qualigen, Palisade Bio, Capienda Biotech, and Lineage Cell Therapeutics all closing rounds between July and August 2025.
Most recent rounds
40 shownRelated listings
Frequently asked
What are the largest disclosed rounds among these 40 Carlsbad companies?
Aptera leads with a $75M venture round closed October 15, 2025. Airspace raised $70M in a Series D in May 2022, followed by Allez Health at $60M (Series A, May 2024) and Carlsmed at $53M (March 2024). ViaSat also received a $53M government grant in April 2022, and Nalu Medical closed a $50M venture round in September 2025.
Which sectors account for most of the funding activity in Carlsbad?
Biotechnology and health care together represent roughly half of the 40 entries shown. Biotech names include Allez Health, Jumpcode Genomics, Palisade Bio, Qualigen, Capienda Biotech, Lineage Cell Therapeutics, Aurora Spine, ALZpath, ChromaCode, Biora Therapeutics, M2 Ingredients, and Progenity. Health care companies include Nalu Medical, Ceresti Health, Carlsmed, SeaSpine, Ra Medical Systems, and View Point Medical.
Is there AI or data company activity in Carlsbad's recent rounds?
Yes. GigaIO closed a $21M Series B on July 17, 2025, Sleep.ai raised $6M in August 2025, and LenderSquared completed a $340K seed round on October 17, 2025. ALT Sports Data also raised a $5M seed in April 2025, adding a sports analytics angle to the city's emerging data and AI deal flow.
What round stages appear most often in Carlsbad?
Undisclosed-stage venture rounds (labeled 'Series Unknown' or 'Venture - Series Unknown') dominate the dataset. Named stages include four seed rounds (LenderSquared, ALT Sports Data, Redemption Games, Challenger), one Series A (Allez Health), three Series B rounds (GigaIO, Amionx, Jumpcode Genomics), two Series D rounds (Airspace, ChromaCode), one pre-seed (MDandMe), one post-IPO debt (SeaSpine), and one post-IPO equity (Progenity).
How active has Carlsbad been in 2025 specifically?
Nine of the 40 entries carry 2025 round dates. The most recent is Instant Hydration's $16M venture round on November 20, 2025. Other 2025 closes include Aptera ($75M, October), Nalu Medical ($50M, September), Sleep.ai ($6M, August), Ceresti Health ($12M, August), Lineage Cell Therapeutics ($12M, August), GigaIO ($21M Series B, July), and ALT Sports Data ($5M seed, April).
What is the typical deal size range visible in Carlsbad rounds?
Disclosed amounts span from $80K (Oral Genome, November 2022) to $75M (Aptera, October 2025). A number of rounds are undisclosed entirely, including those for ALZpath, ChromaCode, Okika Devices, M2 Ingredients, and Plus Delta Partners. Among rounds with disclosed figures, the $4M–$16M range recurs most frequently.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.